Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 5;8(11):e70042.
doi: 10.1002/hem3.70042. eCollection 2024 Nov.

How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann-Pick disease type C from bone marrow and peripheral blood smears

Affiliations

How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann-Pick disease type C from bone marrow and peripheral blood smears

Sandrine Girard et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
May‐Grünwald‐Giemsa‐stained bone marrow and peripheral blood smears. (A) FH and SBH in bone marrow (magnification ×63 and ×100): (a) FH exhibits abundant cytoplasm including numerous small to medium‐sized inclusions, which are primarily white but may also appear dim blue or pink (cases 2, 5, 9, and 18). In some cases, SBH is observed (cases 9 and 18). (b) Vacuolated hematopoietic cells are present in BM including granular neutrophils, eosinophils, monocytes, and plasma cells (cases 2 and 5). (c) Increased adipose tissue is noted (case 2), with fat inclusions sometimes observed among hematopoietic tissue (cases 5 and 18). (B) VL in peripheral blood (magnification x100): VL are characterized by 3 to 6 clustered vacuoles or are aligned in a manner reminiscent of pearls on a string (cases 1 and 6). ASMD, acid sphingomyelinase deficiency; FH, foamy histiocytes; NPC, Niemann‐Pick disease type C; SBH, sea‐blue histiocytes; VL, vacuolated lymphocytes. Clinical neurological form of NPC: LI, late infantile; Unc, uncategorized.

References

    1. Geberhiwot T, Wasserstein M, Wanninayake S, et al. Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann‐Pick disease types A, B and A/B). Orphanet J Rare Dis. 2023;18(1):85. 10.1186/s13023-023-02686-6 - DOI - PMC - PubMed
    1. Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase‐deficient Niemann‐Pick disease. J Inherit Metab Dis. 2007;30(5):654‐663. 10.1007/s10545-007-0632-9 - DOI - PubMed
    1. Wasserstein M, Dionisi‐Vici C, Giugliani R, et al. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD). Mol Gen Metab. 2019;126(2):98‐105. 10.1016/j.ymgme.2018.11.014 - DOI - PMC - PubMed
    1. Doerr A, Farooq M, Faulkner C, et al. Diagnostic odyssey for patients with acid sphingomyelinase deficiency (ASMD): Exploring the potential indicators of diagnosis using quantitative and qualitative data. Mol Genet Metab Rep. 2024;38:101052. 10.1016/j.ymgmr.2024.101052 - DOI - PMC - PubMed
    1. Bolton SC, Soran V, Marfa MP, et al. Clinical disease characteristics of patients with Niemann‐Pick Disease Type C: findings from the International Niemann‐Pick Disease Registry (INPDR). Orphanet J Rare Dis. 2022;17(1):51. 10.1186/s13023-022-02200-4 - DOI - PMC - PubMed

LinkOut - more resources